SCHEMBL367062

SCHEMBL367062

CCC(I)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
MIF P14174 1/20 0.42
TAAR1 Q96RJ0 4/20 0.41
HTR2A P28223 4/20 0.41
HRH1 P35367 3/20 0.41
HKDC1 Q2TB90 1/20 0.41
TRPA1 O75762 1/20 0.41
AOC3 Q16853 1/20 0.39
NOS3 P29474 1/20 0.39
NOS2 P35228 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
POLB P06746 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3477567 0.80 AOC3 (0.46) LMNATAAR1HTR2AHRH1AOC3
SCHEMBL29308038 0.80 LMNA (0.43) LMNAMIFTAAR1HTR2AHRH1
SCHEMBL10935767 0.79 TAAR1 (0.40) LMNATAAR1HTR2AHRH1TDP1
SCHEMBL31190174 0.78 HRH1 (0.46) LMNATAAR1HTR2AHRH1
SCHEMBL169508 0.78 LMNA (0.56) LMNAMIFTAAR1HTR2AHRH1
SCHEMBL8741675 0.77 CHRNA7 (0.41) LMNAHTR2ATDP1MEN1KMT2A
SCHEMBL5034682 0.77 POLB (0.45) LMNAHTR2AHRH1AOC3POLB
SCHEMBL2376253 0.76 TAAR1 (0.42) LMNATAAR1HTR2AHRH1
Ammonia Solution, Strong SCHEMBL1640901 0.76 LMNA (0.54) LMNAMIFTAAR1HTR2AHRH1
SCHEMBL5167170 0.75 AOC3 (0.38) LMNAAOC3TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116406213-A Chemical method for inhibiting ion diffusion in perovskite battery 华东理工大学 2023-07-07 CN claimed
CN-111954848-B Photosensitive resin composition, cured product, insulating material, resin material for solder resist, and resist member DIC株式会社 2024-05-03 CN disclosed
CN-114394923-B Preparation method of N-acyl-2-alkyl indoline compound 浙江工业大学 2024-02-06 CN disclosed
US-20230367214-A1 CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-11-16 US disclosed
WO-2023220439-A1 COMPOSITIONS USEFUL FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. (US) 2023-11-16 WO disclosed
CN-117042473-A Perovskite solar cell and preparation method and application thereof 深圳现象光伏科技有限公司 2023-11-10 CN disclosed
CN-116396137-A Thermodynamically unstable substituted cyclohexane compound and synthesis method thereof 武汉大学 2023-07-07 CN disclosed
US-20230194986-A1 CHEMICALLY AMPLIFIED POSITIVE RESIST COMPOSITION AND RESIST PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-06-22 US disclosed
CN-116209334-A Method for preparing red, green and blue color perovskite pixel array by ink-jet printing and application thereof 华南理工大学 2023-06-02 CN disclosed
US-11407772-B2 Optically-active cyclopentenone derivatives TOHOKU UNIVERSITY (JP) 2022-08-09 US disclosed
US-6462248-B1 THROUGH CONVERSION, ISOMERIZATION AND/OR ADSORPTIVE SEPARATION OF AROMATIC COMPOUNDS TORAY INDUSTRIES, INC. (JP) 2002-10-08 US disclosed
WO-2001087849-A2 MODULATORS OF TNF- ALPHA SIGNALING GENZYME CORPORATION (US) 2001-11-22 WO disclosed
EP-0985649-A2 Method for producing an aromatic compound having an alkyl group with at least three carbon atoms TORAY INDUSTRIES, INC. (JP) 2000-03-15 EP disclosed
EP-0848693-A4 ISOMERIZATION OF BISPHENOLS DOW CHEMICAL CO (US) 1999-03-17 EP disclosed
EP-0848693-A1 ISOMERIZATION OF BISPHENOLS THE DOW CHEMICAL COMPANY (US) 1998-06-24 EP disclosed
WO-1997008122-A1 ISOMERIZATION OF BISPHENOLS THE DOW CHEMICAL COMPANY (US) 1997-03-06 WO disclosed
EP-0682662-A1 BICYCLIC CARBOXYLIC ACID LEUKOTRIENE B 4? ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1995-11-22 EP disclosed
WO-1995015956-A1 BICYCLIC CARBOXYLIC ACID LEUKOTRIENE B4 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1995-06-15 WO disclosed
EP-0534511-A1 HIV protease inhibitors useful for the treatment of aids MERCK & CO. INC. (US) 1993-03-31 EP disclosed
US-4087426-A Oxybisberberine and a process for its production RESEARCH CORPORATION (US) 1978-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11407772-B2 Optically-active cyclopentenone derivatives PTGIS, PTGES, PTGES2 LMNA 2200/4885MIF 2413/4885TAAR1 4061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.